Expression and biochemical characterization of a type I methionine aminopeptidase of Plasmodium vivax

Jung-Mi Kang1, Jung-Won Ju2, Jung-Yeon Kim2

  • 1Department of Parasitology and Tropical Medicine, and Institute of Health Sciences, Gyeongsang National University School of Medicine, Jinju 660-751, Republic of Korea.

Insights

Methionine aminopeptidases (MetAPs) are crucial for protein maturation in Plasmodium parasites. This study characterizes PvMetAP1 from Plasmodium vivax, revealing its biochemical properties and potential as a drug target.

Area of Science:

  • Biochemistry
  • Parasitology
  • Enzymology

Background:

  • Methionine aminopeptidases (MetAPs) are essential enzymes for protein maturation.
  • MetAPs are recognized drug targets for pathogenic protozoa like Plasmodium spp.

Purpose of the Study:

  • To characterize the biochemical properties of a type I MetAP from Plasmodium vivax (PvMetAP1).
  • To evaluate PvMetAP1 as a potential drug target against Plasmodium vivax.

Main Methods:

  • Characterization of recombinant PvMetAP1.
  • Assay of enzyme activity under various pH conditions.
  • Analysis of cofactor requirements and inhibition by specific compounds.

Main Results:

  • PvMetAP1 exhibits conserved residues for metal and substrate binding.
  • Optimal activity at neutral pH (7.5), with stability in neutral/alkaline conditions.
  • Activity is enhanced by Mn(2+) and inhibited by EDTA, fumagillin, amastatin, and bestatin.
  • PvMetAP1 shows specific hydrolytic activity for N-terminal methionine.

Conclusions:

  • PvMetAP1 is a type I MetAP with biochemical properties consistent with its family.
  • PvMetAP1 plays a vital role in Plasmodium vivax physiology through protein maturation.
  • PvMetAP1 represents a promising drug target for treating Plasmodium vivax infections.

Related Concept Videos